Himalaya Nutravedics India Ltd.

• Funding Working Capital Requirements₹13.8 Cr
• Investment in Branding, Digital Marketing and Sales Expansion₹7.5 Cr
• General Corporate Purposes

Our Company has one direct tax case involving a total amount of ₹27.26 Lakhs. The case relates to a proposed disallowance of a deduction under Section 80 IAC due to a delay in filing Form 10CCB. The Company submitted a reply clarifying the form was filed prior to the return and subsequently uploaded, but the response was not accepted. An intimation order dated March 06, 2026, was issued raising a demand of ₹27.26 Lakhs. There are no other material proceedings or criminal litigations involving the Company, Promoters, Directors, or Key Managerial Personnel.

• We may be unable to sufficiently obtain, maintain, protect, or enforce our intellectual property and other proprietary rights. Our trademark applications listed above are currently opposed before the Registrar of Trademarks. Such opposition proceedings may result in delays in registration or refusal of registration of the relevant trademarks, and there can be no assurance that such proceedings will be resolved in our favour. Any adverse outcome in such proceedings may require us to modify, replace, or discontinue the use of the relevant trademarks, which could adversely affect the recognition, reputation and goodwill of our products.(Intellectual Property)

• We derive a significant portion of our revenue from the sale of products in the Ayurvedic products which constituted 94.57%, 92.09% and 79.27% of our revenue from operations for the Fiscals 2026, 2025 and 2024, respectively. Any reduction in demand for these products could have an adverse effect on our business, results of operations, financial condition and cash flows.(Revenue Concentration)

• Our Ayurvedic product portfolio is concentrated across multiple therapeutic areas including but not limited to pain management, infertility, women wellness, gut health, neurological support and general wellness.(Product Concentration)

• Pending conclusion of the opposition proceedings, the Company has undertaken that no fresh packing material bearing the opposed trademark/logo shall be procured and no fresh packing using the opposed trademark shall be undertaken after the existing finished goods and corresponding packing material are exhausted. The Company expects to complete the phased liquidation of the existing inventory bearing the opposed trademark and exhaust the corresponding packing material within six months from the date of the undertaking furnished to the Exchange, or earlier to the extent commercially feasible.(Operational Transition)

• Third parties may infringe, misuse or adopt deceptively similar marks in India or abroad. We may not be able to promptly detect such unauthorised use or take timely and effective steps to enforce our rights, and the remedies available to us may be limited, time-consuming or costly.(Intellectual Property)

• Any failure to obtain, maintain or renew the registration of our trademarks, or to effectively enforce our intellectual property rights, may adversely affect our ability to protect our reputation and goodwill.(Intellectual Property)

• Third-party claims in relation to our trademarks or other intellectual property may result in erosion of our business value, reputational harm and adverse impact on our operations.(Intellectual Property)

• While we have not encountered any unauthorised use of our intellectual property during the Fiscals 2026, 2025, and 2024, we cannot assure you that such protection will be effective in the future.(Intellectual Property)

Each bar is a fixed formula applied to the figures shown above, scored 0–100. This is a reading of what the company disclosed — not a recommendation to apply or avoid, not a price target, and not a prediction of listing performance. Dimensions that could not be extracted are excluded rather than assumed, so coverage varies between documents.